Viewing nowBoriato Tablets (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyeongjin Pharmaceutical Co., Ltd.

MFDS item code 201603144 · Approved 2016.05.31 · Insurance code 660402610
Improvement of hyperlipidemia (including pediatric familial hypercholesterolemia), prevention of cardiovascular disease (e.g., myocardial infarction)
This medication helps to reduce the risk of myocardial infarction, stroke, the need for vascular intervention, angina, and heart failure hospitalization in adults with cardiovascular disease risk factors and in patients with type 2 diabetes. It is also used to lower total cholesterol and LDL cholesterol levels, and to raise HDL cholesterol levels in patients with primary and familial hypercholesterolemia, as well as mixed dyslipidemia. It is useful as an adjunct in certain types of hyperlipidemia that are not controlled by diet. Particularly, it can be used in children aged 10 to 17 years with heterozygous familial hypercholesterolemia, especially in those with a family history of cardiovascular disease or other accompanying risk factors. In summary, this medication helps to enhance cardiovascular health by reducing the risk of cardiovascular disease and improving dyslipidemia.
Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized based on the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: No dose adjustment is necessary, as renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect. Elderly patients: Efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.
Pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine above 20 mg in pediatric patients). The dose should be appropriately adjusted for each patient according to the recommended treatment goal. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms, so patients should immediately inform their doctor if they experience muscle pain, weakness, or severe fatigue. Prior to taking this medication, it is essential to check for any allergic reactions or liver and muscle diseases. Women who are pregnant or breastfeeding should not take this medication. As this medication may affect liver function, regular liver function tests should be conducted, and if symptoms of hepatitis or jaundice occur, the medication should be discontinued. The risk of side effects may increase when this medication is taken with certain other drugs, so it is crucial to inform the doctor or pharmacist of any medications currently being taken. Elderly patients or those with impaired renal function are at a higher risk for muscle disease and require caution during use, and should consult healthcare professionals if symptoms arise. Avoid excessive alcohol consumption and limit the intake of certain foods such as grapefruit juice while taking this medication. Women who may become pregnant should use appropriate contraception while taking this medication, and if pregnancy is confirmed, the medication must be discontinued immediately. Children and those under 10 years of age should not use this medication, and adolescents aged 10 years and older should follow professional guidance. This medication can cause severe muscle side effects such as myopathy or rhabdomyolysis, so if significant muscle pain or weakness occurs, healthcare professionals should be informed immediately. In cases of overdose, there is no specific antidote, treatment should depend on symptoms, and liver function and muscle condition should be checked regularly. Store this medication out of reach of children and keep it in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, ideally at a temperature between 1°C and 30°C (33.8°F and 86°F). Storing it this way helps maintain the medication's effectiveness and prevents degradation.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyeongjin Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.